Intra-Dialytic Hypotension (IDH) Market Analysis: Global Industry Size, Growth and Forecast
Report ID : 1331445 | Published : May 2025 | Study Period : 2023-2033 | Format : PDF + Excel
The market size of the Intra-Dialytic Hypotension (IDH) Market is categorized based on Treatment Type (Pharmacological Treatment, Non-Pharmacological Treatment) and Dialysis Type (Hemodialysis, Peritoneal Dialysis) and End-User (Hospitals, Dialysis Centers, Home Care Settings) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).
Valued at $1.2 billion in 2023, the Intra-Dialytic Hypotension (IDH) Market size is expected to grow to $2.5 billion by 2033, with a CAGR of 8.0% from 2024 to 2033. The report comprises various segments and analyzes the trends and factors playing a substantial role in the market.
Although completely reversible, Intra-Dialytic Hypotension (IDH) is a very common and acute complication observed in a patient receiving dialysis treatment for chronic kidney disease. It is defined as the occurrence of a significant drop in blood pressure between pre-dialysis and during the course of the dialysis session. Classified as the third most common complication, it is a problem that has the potential to even increase the morbidity and mortality rates. The burden of kidney diseases around the world is on the rise and along with that the importance of IDH market trends as a prophylactic measure as important as a clinical treatment protocol. There is growing emphasis, now more than ever, to perform thorough market research for effective management strategies and therapeutic measures.
Significant R&D, technological growth as well as advancement of treatment methodologies aimed at resolution of the relative IDH market are the characteristic features of the IDH market. The development of new monitoring devices, medications and dialysis techniques is changing the market and creating new opportunities for manufacturers and healthcare providers. And also apparent is viewing the IDH more seriously by more doctors and patients with the subsequent expansion of demand for the solutions required for the desired change. As the focus now shifts towards understanding the IDH market, it is critical to first understand the key trends, the competitive analysis and the evolving demands of the various stakeholders in order to conceptualize and implement strong strategies within the IDH market.
| ATTRIBUTES | DETAILS |
| STUDY PERIOD | 2023-2033 |
| BASE YEAR | 2023 |
| FORECAST PERIOD | 2024-2033 |
| HISTORICAL PERIOD | 2023-2024 |
| UNIT | VALUE (USD BILLION) |
| KEY COMPANIES PROFILED | Fresenius Medical Care, Baxter International Inc., DaVita Inc., NantHealth, Medtronic, Nipro Corporation, Asahi Kasei Medical Co. Ltd., DialysisClinic, RenalSense, Keryx Biopharmaceuticals Inc., Rockwell Medical Inc. |
| SEGMENTS COVERED |
By Treatment Type - Pharmacological Treatment, Non-Pharmacological Treatment
By Dialysis Type - Hemodialysis, Peritoneal Dialysis
By End-User - Hospitals, Dialysis Centers, Home Care Settings
By Geography - North America, Europe, APAC, Middle East Asia & Rest of World. |
Intra-Dialytic Hypotension (IDH) Market Dynamics
The Intra-Dialytic Hypotension (IDH) Market is undergoing significant changes due to various dynamic factors. This section delves into the key drivers, restraints, opportunities, and challenges that are shaping the market landscape.
Market Drivers
- Technological Advancements
- Increasing Consumer Demand
- Regulatory Support
- Globalization
Market Restraints
- High Operational Costs
- Regulatory Challenges
- Market Saturation
Market Opportunities
- Emerging Markets
- Product Innovation
- Strategic Partnerships
Market Challenges
- Technological Disruptions
- Supply Chain Issues
- Changing Consumer Preferences
Intra-Dialytic Hypotension (IDH) Market Segmentations
Market Breakup by Treatment Type
- Overview
- Pharmacological Treatment
- Non-Pharmacological Treatment
Market Breakup by Dialysis Type
- Overview
- Hemodialysis
- Peritoneal Dialysis
Market Breakup by End-User
- Overview
- Hospitals
- Dialysis Centers
- Home Care Settings
Market Breakup by Region
North America
- United States of America
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Others
Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
Latin America
- Brazil
- Argentina
- Mexico
- Others
Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Key Players in the Intra-Dialytic Hypotension (IDH) Market
This report provides an in-depth analysis of both established and rising industry participants. It provides broad lists of important companies organized by the types of products they offer and other market-related factors. In addition to characterizing these companies, the report contains the year each player entered the market, which is useful for research analysis by the study's analysts.
- Fresenius Medical Care
- Baxter International Inc.
- DaVita Inc.
- NantHealth
- Medtronic
- Nipro Corporation
- Asahi Kasei Medical Co. Ltd.
- DialysisClinic
- RenalSense
- Keryx Biopharmaceuticals Inc.
- Rockwell Medical Inc.
Customization Options
Verified Industry Insights offers one of the following report customization options to our respectable clients :
Company Profiling
● Detailed profiling of additional market players (up to three players)
● SWOT analysis of key players (up to three players)
Competitive Benchmarking
● Benchmarking of key players on the following parameters : Product portfolio, geographical reach, regional presence, and strategic alliances.
Custom Research
Verified Industry Insights offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected] or call us at +1 743 222 5439
© 2024 Verified Industry Insights. All Rights Reserved